Sector portfolio · Growth fund · United States
De Novo Ventures' Biotech portfolio
De Novo Ventures has backed 10 Biotech startups in rounds we track, $793M between them, shown by the stage each has reached. The best-funded is Endogastric Solutions.
Funding by segment
- Series B$71M4
- Series C and later$269M4
- Stage not reported$454M2
Where they are based
- United States9$770M
United StatesFounded
Total raised
- Under $1M0
- $1M to $10M2
- $10M to $50M5
- $50M to $250M2
- $250M to $1B1
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
10 of 10 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States9
Startups by country, 1 country in all.
Segment by segment
Series B
4 startups · $71M raised
RenovisRenovis,is a biopharmaceutical company developing drugs to treat neurological diseases and disorders.United States$34M- SSSierra SurgicalSieraa Surgical develops minimally-invasive surgical systems based on female sterilization technologies.United States$22M
- OOvalisOvalis is a biotechnology company that develops catheter-based medical devices for the repair of cardiovascular defects.United States$8.5M
- CCartilixCartilix develops and commercializes biomaterials to repair damaged tissues in articular joints and other applications.United States$6.3M
Series C and later
4 startups · $269M raised
AvedroAvedro is a medical device and pharmaceutical company advancing the science and technology of corneal cross-linking.United States$203M- LLumendLumend is a Health Care company.-$23M
- ISiScience SurgicalIscience Surgical develops and offers high resolution imaging systems and microsurgical instruments.United States$22M
- FFlowMedicaFlowMedica is a medical device company which produces intravascular systems for implementing targeted renal therapy.United States$21M
Stage not reported
2 startups · $454M raised
EndoGastric SolutionsEndoGastric Solutions is a medical device company based in Redmond, Washington.United States$293MEBR SystemsEBR Systems is a provider of wireless cardiac pacing system for millions of patients suffering from cardiac rhythm diseases.United States$161M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names De Novo Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like De Novo Ventures?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.